Doubling up in battle to beat cholesterol - Pharmaceutical Business Review

" Dyslipidemia, or high blood cholesterol, is one of the most prevalent conditions in the western world. The rise in obesity and type 2 diabetes and the growing awareness of metabolic syndrome is expected to significantly increase diagnosis. Fortunately, there is no shortage of drug manufacturers willing to invest in the market, which already boosts the world's best selling drug."

Doubling up in battle to beat cholesterol - Pharmaceutical Business Review